Biotech Stocks: Facet, InterMune lead drug stocks north
Source: MarketWatch
Wednesday 10th March, 2010
BOSTON (MarketWatch) -- Facet Biotech Corp. and InterMune Inc. were the lead advancers among the U.S.-traded biotech issues Wednesday, with both stocks rocketing over 60% in early trading.
Facet ...
Read the full story at
MarketWatch
Email this story to a friend
Have your say on this story